Adjust Font Sizing:

New IH Clinical Trial

May 13th, 2020

If you have idiopathic hypersomnia you may be able to help with research to develop a new treatment option.

What is the purpose of the Sparkle 2002 Study?
The SPARKLE 2002 Study is testing an investigational drug in people with narcolepsy with cataplexy. The main purpose of the study is to look at how safe and tolerable the investigational drug is and how it may affect a person’s narcolepsy symptoms.

Study participation eligibility

About 40 people are expected to participate. You may qualify if you:
– Are 18–75 years old
– Have been diagnosed with idiopathic hypersomnia (IH)
– First experienced the effects of hypersomnia when you were between 10 and 30 years of age
– Are willing to stop smoking and give up all nicotine use during the study
– Are willing to give up all caffeine during the study
– Meet additional requirements as determined by a screening process

You will be reimbursed for your time and travel. You may also be eligible to receive compensation for participating in and/or completing the study. The study doctor or staff will discuss this and all other aspects of study participation with you.

To learn more about the Sparkle 2002  Study and to see if you may qualify, visit https://www.sparkle2002ih.com/. See this flyer for more information.

# # #
Date Created: May 13th, 2020
Last Updated: May 14th, 2020

Do NOT follow this link or you will be banned from the site!